MARIBEL RODRIGUEZ: Open Payments
NPI 1760973051 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 76 payments from 14 companies in 2025. Trend: 2023 $2,283 · 2024 $2,222 · 2025 $1,948
Food & beverage: $1,948
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $422 |
| E.R. Squibb & Sons, L.L.C. | 11 | $300 |
| Vanda Pharmaceuticals Inc. | 9 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $256 |
| Lundbeck LLC | 8 | $186 |
| Axsome Therapeutics, Inc. | 5 | $139 |
| ABBVIE INC. | 5 | $106 |
| Alkermes, Inc. | 4 | $84 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Luye Pharma (USA) Ltd. | 2 | $37 |
Products named: UZEDY, COBENFY, HETLIOZ, CAPLYTA, REXULTI, Auvelity, VRAYLAR, ARISTADA.
Industry payments across FL — which companies pay providers there.
